Lv7
5605 积分 2020-10-14 加入
Novel Combination Strategies With Investigational Agents for Functional Cure of Chronic Hepatitis B Infection
3个月前
已完结
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
3个月前
已完结
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial
3个月前
已完结
Modern diagnostic technologies for HIV
3个月前
已完结
Inherent symmetry and flexibility in hepatitis B virus subviral particles
3个月前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
3个月前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
3个月前
已完结
Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose
3个月前
已完结
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B
3个月前
已完结
Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV‐1 B and non‐B subjects with low viraemia
3个月前
已完结
miR-638 in circulating leukaemia cells as a non-invasive biomarker in diagnosis, treatment response and MRD surveillance of acute promyelocytic leukaemia
皖公网安备34019202002308
